BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33834859)

  • 1. Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study.
    Yuan S; Burgess S; Laffan M; Mason AM; Dichgans M; Gill D; Larsson SC
    J Am Heart Assoc; 2021 Apr; 10(8):e019644. PubMed ID: 33834859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Genetically Predicted Iron Status and Cardiovascular Disease Risk: A Mendelian Randomization Study.
    Barad A; Clark AG; Pressman EK; O'Brien KO
    J Am Heart Assoc; 2024 Jun; 13(11):e034991. PubMed ID: 38818967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety of genetically proxied interleukin-5 inhibition: A mendelian randomization study.
    Alton P; Hughes DM; Zhao SS
    Respir Investig; 2023 Mar; 61(2):149-152. PubMed ID: 36682083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
    Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study.
    Levin MG; Klarin D; Assimes TL; Freiberg MS; Ingelsson E; Lynch J; Natarajan P; O'Donnell C; Rader DJ; Tsao PS; Chang KM; Voight BF; Damrauer SM;
    JAMA Netw Open; 2021 Jan; 4(1):e2034461. PubMed ID: 33464320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
    Georgakis MK; Gill D; Rannikmäe K; Traylor M; Anderson CD; Lee JM; Kamatani Y; Hopewell JC; Worrall BB; Bernhagen J; Sudlow CLM; Malik R; Dichgans M
    Circulation; 2019 Jan; 139(2):256-268. PubMed ID: 30586705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries.
    Linden AB; Clarke R; Hammami I; Hopewell JC; Guo Y; Whiteley WN; Lin K; Turnbull I; Chen Y; Yu C; Lv J; Offer A; Bennett D; Walters RG; Li L; Chen Z; Parish S;
    PLoS Med; 2022 Apr; 19(4):e1003967. PubMed ID: 35452448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Traits and Stroke Risk in Individuals of African Ancestry: Mendelian Randomization Analysis.
    Fatumo S; Karhunen V; Chikowore T; Sounkou T; Udosen B; Ezenwa C; Nakabuye M; Soremekun O; Daghlas I; Ryan DK; Taylor A; Mason AM; Damrauer SM; Vujkovic M; Keene KL; Fornage M; Järvelin MR; Burgess S; Gill D
    Stroke; 2021 Aug; 52(8):2680-2684. PubMed ID: 34078102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.
    Wang K; Shi M; Huang C; Fan B; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Cardiovasc Diabetol; 2022 Sep; 21(1):192. PubMed ID: 36151532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
    Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using Mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants.
    Borges MC; Haycock PC; Zheng J; Hemani G; Holmes MV; Davey Smith G; Hingorani AD; Lawlor DA
    BMC Med; 2022 Jun; 20(1):210. PubMed ID: 35692035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Glycated Hemoglobin (HbA
    Au Yeung SL; Luo S; Schooling CM
    Diabetes Care; 2018 Sep; 41(9):1991-1997. PubMed ID: 29950300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
    Ellervik C; Mora S; Kuś A; Åsvold B; Marouli E; Deloukas P; Sterenborg RBTM; Teumer A; Burgess S; Sabater-Lleal M; Huffman J; Johnson AD; Trégouet DA; Smith NL; Medici M; DeVries PS; Chasman DI; Kjaergaard AD
    Thyroid; 2021 Sep; 31(9):1305-1315. PubMed ID: 34210154
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma Phospholipid Fatty Acids,
    Yuan S; Bäck M; Bruzelius M; Mason AM; Burgess S; Larsson S
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk.
    Harlow CE; Patel VV; Waterworth DM; Wood AR; Beaumont RN; Ruth KS; Tyrrell J; Oguro-Ando A; Chu AY; Frayling TM
    Hum Mol Genet; 2023 Jan; 32(3):496-505. PubMed ID: 36048866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red and processed meat intake and risk of cardiovascular disease: A two-sample Mendelian randomization study.
    Hu B; He X; Sun H; Hu Y; Li F; Sun Y; Sun J; Feng L
    Clin Nutr ESPEN; 2024 Apr; 60():289-297. PubMed ID: 38479924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study.
    Yuan S; Mason AM; Carter P; Burgess S; Larsson SC
    BMC Med; 2021 Apr; 19(1):97. PubMed ID: 33888102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.